Skip to main content

HighTower Advisors, LLC

SEC CIK
0001462245
Latest filing
Aug 25, 2026

GANX holding history

Gain Therapeutics, Inc. in every 13F filed by HighTower Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GANX overviewAll 13F holders of GANXFull Q2 2026 holdings

Shares (Q2 2026)
17,174
Value
$34.9K
% of portfolio
<0.1%
Quarters held
2
Since Q3 2025
Holdings of GANX by HighTower Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202617,174$34.9K<0.1%+17,174NewHolders
Q4 20250$00.0%−11,574−100.0%Sold outHolders
Q3 202511,574$20.5K<0.1%+11,574NewHolders